article ® check for updates | open sars-cov-2 infection rewires host cell metabolism and is potentially susceptible to mtorc1 inhibition peter j  mullen   gustavo garcia jr2  arunima purkayastha®  nedas matulionis®|  ernst w  schmid!  milica momcilovic   chandani sen   justin langerman!  arunachalam ramaiah®  david b  shackelford@  °®  robert damoiseaux2©  8   samuel w  french® ©10  kathrin plath 14 69 11 brigitte n  gomperts  4 69 1) vaithilingaraja arumugaswami2® 2 & heather r  christofk@ 16112  viruses hijack host cell metabolism to acquire the building blocks required for replication  understanding how sars-cov -2 alters host cell metabolism may lead to potential treatments oe for covid-19  here we profile metabolic changes conferred by sars-cov-2 infection in ernme f ip kidney epithelial cells and lung air-liquid interface (ali) cultures  and show that sars-cov-2he 3 a  ye gi infection increases glucose carbon entry into the tca cycle via increased pyruvate carbox- wi © ae a ylase expression  sars-cov-2 also reduces oxidative glutamine metabolism while maintaining jim es et reductive carboxylation  consistent with these changes  sars-cov-2 infection increases the says eis +  ore activity of mtorc1 in cell lines and lung ali cultures  lastly  we show evidence of mtorc1 9 og a s   _— activation in covid-19 patient lung tissue  and that mtorc1 inhibitors reduce viral replication ef   3 % ws in kidney epithelial cells and lung ali cultures  our results suggest that targeting mt orc1 may © ice ao be a feasible treatment strategy for covid-19 patients  although further studies are required to determine the mechanism of inhibition and potential efficacy in patients  en i | — ive nature communications| (2021)12 1876 | https //doi org/10 1038/s41467-021-22166-4 i  01/05/29  e e e e sars-cov-2 messes with the citric acid e e (tca) cycle of infected kidney and lung cells > pyruvate entry using pyruvate carboxylase is increased > oxidative use of glutamine is reduced upon infection 3- 8c-glucose labeling glucose 0 25 i mock pyruvate b oolpoor mm virus ram noc pet! |pc |jacetyl-coa 8 0 15 —t p0001 b oxidative l citrate « hy       _ 0 5 p<0 001 p0 001 neek oxaloacetate aconitate a 0 10 eg 8 oad     mm virus / \ g 0 05 g p<0 001 malate isocitrate r g 03 p0001 5 ( } re)   os ° ° 3 ° 3 8 0 2 fumarate = a-kg <= glutamate spos e s \ see] / ° rot os ra bo succinate succinyl-coa glutamine ww <-_— 0 0   nj wo nd nd ty ns ss na oe   ae ul a s s oe ~ se 2 = 01/05/22  9 e e e master regulator mtorci’s activity is e e e e increased during sars-cov-2 infection a vero cells (24 hr) metabolism sars-cov-2 - + _§—— shee [oe | tc atf4 s6k1 lipin-1 hif1o so [sm| | ft | - 25 kda actin [== | mthfd2 cad \> srebps ppary - 37 kda 7 ow nadph xygen | jutrients stress growth \\ lyae > glycerol sacana  / \~ glucosea \oonat joi  tind seaver nucleotide aerobic so gaa | gor) ae) a b mtorc1 must8 slven mtor l   spemein am mr)   | ls -_ mtor t 3 liu & sabatini (2020) nat  rev  mol  cell biol  21  183-203  mtorci1 inhibitors reduce sars-cov-2 infection in air-liquid interface (ald) cells d mucociliary ali cultures serneeeivi glucose = mane   1 p=0 004 > 1—_— e 10 (giycolysis) «== mtor— rapamycin ro)   compound§68 é 2 0 8 | % on wicassia) 3% 0 6   sz/i ll °vv  3 os es mk d y 04 see os ciate bo } z 0 2 cell death gz 0 0   tanaka et al  j  clin  invest  125 (2015) 1591-1602 sars-cov-2 - + + ca rapamycin - uf 4  